You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A novel chemotactic factor inhibitor (CFI) was found in 37% of uremic patients, inactivating key immune factors. This may explain the higher infection rates observed in uremia.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: